• Home
  • News
2021-11-01 | views:1546
Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?
2021-10-28 | views:743
한미사이언스-英 옥스퍼드대, 팬데믹 사이언스 동맹 협약 체결
2021-10-25 | views:1456
Immune response to mRNA COVID vaccines delayed in pregnant women
2021-10-25 | views:1511
Mr Chong-Yoon Lim of Hanmi Science appointed as a Director
2021-10-20 | views:2910
An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders
2021-10-19 | views:1649
Is mRNA the Future of Drug Development?
2021-10-18 | views:1498
Should you mix and match COVID-19 vaccines? Experts weigh in.
2021-10-17 | views:797
기술 확보 나선 mRNA…원부자재 국산화 숙제
2021-10-08 | views:1495
‘디지털 치료제’ 새 패러다임 될까?
  1.   
  2. 37
  3. 38
  4. 39
  5. 40
  6. 41
  7. 42
  8. 43
  9.   
  • 서울시 금천구 디지털로 173, 10층 (가산동, 엘리시아)
  • 대표 번호 : 02-890-8700
  • 주주 문의 : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

개인정보 처리방침 사용자 이용약관 twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.